explore -WSS

explore

author：Wikipedia 2025-09-30 18:43:06 - browse：393

Allergan, Dom Smith/STAT

It wasn’t supposed to work out this way for Brent Saunders.

Four years ago, Saunders was the whiz kid of the pharmaceutical set. At 44, he had created a large pharmaceutical firm, then called Actavis, almost by force of will after engineering more than $100 billion in deals in a two-year span. Then he had swooped in to rescue Botox maker Allergan from the nefarious claws of Valeant Pharmaceuticals, an asset-stripping drug company loved by many on Wall Street but no one with a conscience.

As CEO, he paired his dealmaking with a boyish charm and a willingness to take on big issues that made him seem like a potential spokesman for the whole industry.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： PEPFAR is under serious threat — and so is global health

focus

hotspot

WSS

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Medicare Advantage plans can’t deny care with AI, CMS warns

The Biogen Aduhelm mess could happen again

White House touts steps to stem shortages of cancer treatments

Regeneron agrees to White House price limits on anti

The Biogen Aduhelm mess could happen again

hotspot

explore

entertainment

Jerome Adams on the need for new antivirals for Covid

Food makers tried to stack nutrition panel with preferred experts

Wildfire smoke exposes gaps in outdoor worker protections

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Wildfire smoke exposes gaps in outdoor worker protections

A single Democrat is willing to weaken Medicare negotiation power

Duchenne breakthrough therapy leaves behind pioneering families

Surgery pushed Ben Carson to fame

Supreme Court strikes down use of affirmative action

Hospitals consider fixing cancer drug shortages on their own

leisure time

Hospitals consider fixing cancer drug shortages on their own

Global cancer cases to surge 77% by 2050, WHO report says

Pig kidney works a record two months in donated body

Devoted Health’s losses in Medicare Advantage persist

Popular nasal decongestant doesn't actually relieve congestion

Why Novartis is going to walk from its acquisition of MorphoSys

focus

hotspot

focus

leisure time